Last edition
News about "Newron Pharmaceuticals SpA"
Newron Reviews FDA Feedback on Evenamide Clinical Hold in US
Newron Pharmaceuticals is reviewing FDA feedback on the clinical hold in US study centres for its Phase 3 ENIGMA-TRS 2 trial of evenamide following potential cardiac safety concerns.
Newron Pharmaceuticals SpA | 12/10/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members